Testing effectiveness (Phase 2)Study completedNCT02314156
What this trial is testing
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierDuctal Breast Carcinoma In Situ+6 more
Northwestern University 67